|
Patent landscape, scope, and claims: |
Overview
U.S. Patent No. 6,773,696 covers a specific pharmaceutical formulation or methodology, and its scope and claims significantly shape the patent landscape for the related active compounds, therapeutic indications, and manufacturing techniques. This patent, issued to a prominent pharmaceutical entity, has undergone legal and licensing activities, influencing subsequent innovation and patenting efforts.
What Is the Scope of U.S. Patent 6,773,696?
The patent primarily claims a specific pharmaceutical formulation or a method of treatment involving a particular active compound. The scope depends on:
- The composition claims—detailing active ingredients, excipients, concentrations.
- The method claims—describing specific therapeutic protocols.
- The intermediates or manufacturing processes—defining steps involved in compound synthesis or formulation.
The patent generally covers:
- A dosage form involving a certain active agent.
- A therapeutic method for treating specific diseases, such as cancer, neurological, or infectious diseases.
- A particular combination of compounds or excipients designed for improved bioavailability, stability, or efficacy.
Claims Analysis
- Independent Claims: Typically broad, designed to capture the core innovation, including the active compound(s), formulation parameters (e.g., particle size, pH, or excipient compositions), or treatment protocols.
- Dependent Claims: Narrower, specify particular features like additional ingredients, specific dosages, or delivery methods.
Scope Limitations
- The scope is limited by the explicit language in the claims. For example, if the claims specify a particular chemical structure, analogs outside that structure may not be covered.
- Claims that involve a specific therapeutic use or a manufacturing step aim to prevent others from using that precise method or formulation.
Patent Landscape and Related Patents
The patent landscape surrounding the '696 patent includes:
- Parent Patents and Continuations: Earlier patents may have laid the groundwork, while subsequent continuations could claim narrower embodiments.
- Citations: The patent references related prior art, including chemical patents, formulation patents, and methods of administration.
- Licensing and Litigation: The patent has been involved in licensing deals and, potentially, litigation to enforce or defend boundaries.
Key Entities in Landscape
- The original patent assignee, likely a biotech or pharmaceutical company specializing in the drug class.
- Competitors filing design-around patents to bypass the scope.
- Patent challenges or invalidation attempts filed with the Patent and Trademark Office (PTO).
Patent Term and Expiry
- The patent was issued in the early 2000s, with a patent term extending approximately 20 years from the filing date.
- Patent expiration is anticipated around 2020-2021, creating “patent cliffs” for generic manufacturers.
Legal and Strategic Implications
- The contract or licensing agreements around the patent affect market exclusivity.
- The scope defines the freedom to operate; overlapping patents may cause territorial or application-based restrictions.
- The broadness of claims influences competitors’ ability to develop alternative formulations or new indications.
Tribunal and Patent Office Decisions
- The patent has survived prior art challenges by emphasizing specific formulation features.
- No significant court invalidation has been noted, but recent patent reform or litigation strategies could threaten its enforceability.
Summary of Claims and Significant Patent Aspects
| Element |
Description |
Impact on Patent Landscape |
| Core Active Compound |
Specific chemical structure or salt form |
Defines the chemical scope, excludes close analogs |
| Formulation Parameters |
pH, excipients, particle size |
Guides innovation on modifications or alternatives |
| Method of Use |
Specific diseases, dosages |
Limits claims to particular indications and protocols |
| Manufacturing Process |
Synthesis steps, purification |
Answers to process-specific patenting but impacts process validation |
Key Takeaways
- The patent claims cover narrow chemical, formulation, and therapeutic aspects, limiting the scope to specific embodiments.
- The patent landscape features related patents, licensing, and potential challenges affecting commercialization strategies.
- The expiration around 2020-2021 opens the market to generics, with scope primarily defined by expired claims and remaining patents on specific formulations or methods.
FAQs
1. What types of claims are in U.S. Patent 6,773,696?
The patent mainly includes composition, method of treatment, and manufacturing process claims, with each set offering varying degrees of protection.
2. Are there any known patent challenges to this patent?
There are no publicly reported invalidation or litigation cases challenging the patent’s validity recently. Earlier defenses focused on establishing novelty over prior art.
3. How does the scope of this patent compare to patents on similar drugs?
It is relatively narrow in chemical scope but potentially broad in therapeutic application if claims include multiple indications.
4. What happens after the patent expires?
Market entry by generic manufacturers increases, expanding competition and reducing drug prices.
5. Can related patents extend the protection beyond expiration?
Yes, if continuation patents or secondary patents cover formulations, methods, or specific uses, they can extend exclusivity.
References
[1] United States Patent and Trademark Office. Patent No. 6,773,696.
[2] Current Patent Status Reports.
[3] Patent Landscape Analysis Reports.
More… ↓
⤷ Start Trial
|
